[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:esophageal-adenocarcinoma:claudin-18-isoform-a2":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Esophageal Adenocarcinoma","Claudin-18 Isoform A2",4,[8,16,22,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07432295","Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)",[12],"Phase 2","RECRUITING","2026-08-26T02:15:45.413021Z","2026-05-05T02:43:29.196980Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07069712","A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma",[12],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:28.835650Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06005493","Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors",[26],"Phase 1\u002FPhase 2","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:28.867321Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07546812","Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas",[12],"2026-08-26T02:16:10.529598Z","2026-07-19T19:36:05.144248Z"]